NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Intel Shares Soar Amid Short-Seller Woes

A remarkable rally in Intel Corp. shares has left traders who bet against the company facing significant losses. Since hitting a low on March 30, the chipmaker's stock price has surged 214%, adding more than $440 billion to its market capitalization. According to data from S3 Partners, short-sellers are now facing paper losses of over $12 billion.

This unprecedented rise has pushed short interest in Intel shares as a percentage of the company's float to near a 52-week high. The stock has been fueled by a report that Intel reached a preliminary chip-making agreement with Apple Inc. Intel's latest move is also being driven by a sales forecast that exceeded Wall Street's expectations.

Comparison of Chip Stocks

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

StockPerformance in 2026 (since late March)
Intel Corp.214%
Micron Technology Inc.
Advanced Micro Devices Inc.
Sandisk Corp.

Note: Data from S3 Partners.

Intel's meteoric rise has also seen it become the top performer in the S&P 500 Index since the start of April, outpacing even high-flying Sandisk Corp. The chipmaker index as a whole is up almost 60% since the start of April, with its 14-day relative strength index recently hitting its highest since 2011.

Investors are hesitant to test the rally, citing the unpredictability of momentum. Portfolio manager Thomas George at Grizzle Investment Management, which owns Intel shares, said, "I would not short any of these stocks. This is not a sector where glory can be found for a short seller."

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Despite its sky-high market valuation, Intel's market capitalization is still being raised by Wall Street. Analyst estimates for Intel's 2026 adjusted earnings per share have more than doubled in just the last month, according to data compiled by Bloomberg. The shares trade at more than 100 times earnings expected over the next 12 months, their highest multiple ever and roughly five times their 10-year average.

However, this expensive multiple could quickly become cheap if growth picks up, according to George. "If AI leads to more efficiency, more people will use it, which means more demand."

Even with the growing optimism about Intel's outlook, Wall Street is hardly bullish on the stock. The average analyst price target of about $85 implies a 34% decline from Monday's closing price. This is the weakest implied return among all members of the semiconductor index. Of the 53 analysts tracked by Bloomberg who cover the stock, just 17 have buy ratings and three have sells.

In the coming 12 months, there's a decent chance that some high-momentum stocks like Intel will experience significant selloffs, potentially as severe as 30%, George said. However, the momentum in the stock and the improvement in the company's fundamentals make trying to time any reverse perilous.

Investor Takeaway

Betting against Intel comes with considerable risk due to its strong momentum.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.